Compound dependent parameters optimized to hydroxybupropion glucuronide
| Analytes | Q1/Q3 | DP | EP | CEP | CE | CXP |
|---|---|---|---|---|---|---|
| m/z | v | v | v | v | v | |
| Erythro-hydrobupropion | 242.10/168.00 | 36 | 5.5 | 12 | 24 | 3 |
| EGLUC 1 | 418.00/168.00 | 45 | 8.5 | 30 | 35 | 5 |
| EGLUC 2 | 418.00/168.00 | 45 | 8.5 | 30 | 35 | 5 |
| Threo-hydrobupropion | 242.10/168.00 | 36 | 5.5 | 12 | 24 | 3 |
| (1R,2R)-hydrobupropion glucuronide | 418.00/168.00 | 45 | 8.5 | 30 | 35 | 5 |
| (1S,2S)-hydrobupropion glucuronide | 418.00/168.00 | 45 | 8.5 | 30 | 35 | 5 |
| hydroxybupropion | 256.00/238.00 | 30 | 5.5 | 25 | 24 | 4 |
| (S,S)-hydroxybupropion glucuronide | 432.00/184.00 | 56 | 8.5 | 16 | 24 | 3 |
| (R,R)-hydroxybupropion glucuronide | 432.00/184.00 | 56 | 8.5 | 16 | 24 | 3 |
CE, collision energy; CEP, cell entrance potential; CXP, collision cell exit potential; DP, declustering potential; ELGUC, erythro-hydrobupropion glucuronide; EP, entrance potential.